CIK 0000863894
- Non-accelerated filer
- Smaller reporting company
VERU INC.
Sign in to watch- Ticker
- VERU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- WI
- Entity type
- Operating
- EIN
- 391144397
- Phone
- +1 312-595-9123
- Business address
- 2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
- Former names
- FEMALE HEALTH CO
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $2.76 ($13,800)
- 4 Open-market buy CAO and CFO bought 5,000 shares at $2.65 ($13,233)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 1,000 shares at $4.47 ($4,470)
- 4 Open-market buy Director bought 1,000 shares at $4.51 ($4,510)
- 4 Open-market buy Director bought 5,000 shares at $4.27 ($21,350)
- 4 Open-market buy Director bought 5,000 shares at $2.80 ($14,000)
- 4 Open-market sale President and CEO sold 25,000 shares at an average $2.21 ($55,340)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 25,000 shares at an average $1.99 ($49,766)
- 4 Open-market sale President and CEO sold 15,836 shares at an average $2.06 ($32,593)
- 4 Open-market sale President and CEO sold 14,164 shares at an average $2.11 ($29,954)
- 4 Open-market sale President and CEO sold 30,000 shares at an average $1.93 ($57,919)
Page 6 of 30 · 594 filings